Faculty Information - Eiichi Tanaka

（Last updated : 2024-03-26 10:47:26）

Eiichi Tanaka
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Rheumatology

Position Associate Professor

■ Academic conference presentation

1.	Real world evidence of treatment effectiveness and unfavorable clinical events for elderly-onset early rheumatoid arthritis in Japan: Results from the IORRA study 2022/11/12
2.	Relationship between disease activity by JADAS-27, SDAI, and DAS-28 and subsequent 2022/06
3.	Current status of rheumatoid arthritis cohort in Japan. APLAR COPCORD Epidemiology- Rheumatoid Arthritis 2021/08
4.	Medical cost and resource use in patients starting treatment for rheumatoid arthritis treated with and without corticosteroids in Japan 2021/06
5.	Medical costs for patients starting treatment for rheumatoid arthritis who have comorbid diabetes mellitus in Japan 2021/06
6.	Factors associated with treatment response in patients with elderly-onset rheumatoid arhthritis: 3-year observation using IORRA cohort 2020/08/04
7.	Factors associated with treatment response in patients with elderly-onset rheumatoid arhthritis: 3-year observation using IORRA cohort 2020/06/03
8.	Status of disease activity,functional impairment and treatment in patients with rheumatoid arthritis and comorbidities. 2015/06
9.	The minimally important difference in the European quality of life-five dimensions(EQ-5D) in patients with rheumatoid arthritis based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort. 2014/11/16
10.	Treatment for Rheumatoid arthritis patients after a lymphoproliferative disorder. 2014/06/13
11.	Functional Disability and Quality Of Life Are More Likely Improved In Patients With Rheumatoid Arthritis Who Achieved The New ACR/EULAR Remission Criteria Compared To DAS28 Remission In Daily Practice 2013/10
12.	Assessment of work productivity and activity impairment in patients with rheumatoid arthritis based on the institute of rheumatology rheumatoid (IORRA) cohort datebase. 2013/06/13
13.	Clinical factors associated with the progression of functional impairment in rheumatoid arthritis patients who maintained the remission criteria defined by the new ACR/EULAR criteria. 2013/06
14.	Evaluation of the new remission criteria from EULAR/ACR in daily practice based observational cohort IORRA. 2011/05/26
15.	Improvement in disease activity of Japanese patients with rheumatoid arthritis from 2000 to 2010 based on the long-term observational cohort IORRA. 2011/05/26
16.	Serum uric acid levels relates to disease activity in patients with rheumatoid arthritis 2011/02
17.	Suppression of disease activity with methotrexate and/or TNF inhibitors but not corticosteroid ameliorates the functional disability of RA patients in a large prospective cohort study. 2010/06/19
18.	Genetic Contribution to the Clinical Features of Rheumatoid Arthritis 2010/06
19.	Analysis of RA patients without biologics despite the sustaining high disease activity in a Japanese prospective observational cohort 2009/06
20.	Euro QOL (EQ-5D) based QOL in 5,023 Japanese patients with rheumatoid arthritis in an observational cohort IORRA 2009/06
21.	Incidence of malignancies in Japanese patients with rheumatoid arthritis ?Analysis of IORRA cohort 2009/06
22.	Iucidence of malignancies in Japanese patients with rheumatoid arthritis-analysis of IORRA cohort 2009/06
23.	Which joint improvement contributed in the better functional disability in patients with RA 2009/06
Display 5 items
Display all(23)